drugset
drugset / Trial / NCT01326780

A Study of a New Drug Treatment for Acne

NCT01326780 ↗

Phase 2 Completed 431 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to determine if three different doses of a new acne treatment are safe and better at reducing facial acne than a treatment without active ingredient.

Timeline

Start
2011-03-31
Primary completion
2012-03-31
Completion
2012-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ 10229570-AAA Unknown 1.2 % Topical
Subject JNJ 10229570-AAA Unknown 2.4 % Topical
Subject JNJ 10229570-AAA Unknown 3.6 % Topical

Indications

acne